NextCell Pharma AB (FRA:65G)

NextCell Pharma AB Ratios and Metrics

Market cap in millions EUR. Fiscal year is September - August.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Feb 23, 2026	Aug 31, 2025	Aug 31, 2024	Aug 31, 2023	Aug 31, 2022	Aug 31, 2021
Market Capitalization	16	12	8	10	20	49
Market Cap Growth	-15.49%	43.77%	-21.57%	-48.86%	-58.29%	104.37%
Enterprise Value	12	10	6	5	10	34
Last Close Price	0.16	0.09	0.07	0.29	0.59	1.41
PS Ratio	16.09	11.78	8.23	8.87	35.05	111.90
PB Ratio	2.68	1.96	1.37	1.63	1.89	3.32
P/TBV Ratio	2.68	1.96	1.37	1.63	1.89	3.32
EV/Sales Ratio	12.00	10.27	6.39	4.34	17.86	78.06
Net Debt / Equity Ratio	-0.58	-0.58	-0.69	-0.66	-0.84	-0.93
Net Debt / EBITDA Ratio	1.16	1.16	1.11	1.23	2.81	5.71
Net Debt / FCF Ratio	0.90	0.90	1.24	1.04	2.37	5.29
Asset Turnover	0.14	0.14	0.13	0.13	0.04	0.05
Inventory Turnover	17.24	17.24	22.79	14.12	-	-
Quick Ratio	8.05	8.05	5.06	5.32	14.40	35.60
Current Ratio	10.02	10.02	6.15	6.67	15.40	37.02
Return on Equity (ROE)	-52.46%	-52.46%	-58.55%	-41.63%	-26.02%	-27.86%
Return on Assets (ROA)	-28.39%	-28.39%	-31.72%	-24.01%	-15.62%	-16.73%
Return on Capital Employed (ROCE)	-50.30%	-50.30%	-60.50%	-52.10%	-29.80%	-16.40%
Earnings Yield	-19.74%	-26.96%	-45.20%	-32.17%	-15.83%	-4.93%
FCF Yield	-24.18%	-33.03%	-40.79%	-38.72%	-18.74%	-5.28%
Buyback Yield / Dilution	-87.22%	-87.22%	-18.72%	-	-13.05%	-53.09%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.